Clinical Trial: Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Observational Post Authorisation Safety Study to Describe the Safety Profile of the Diphtheria, Tetanus, Acellular Pertussis Combination Vaccine, Reduced Antigen Content (

Brief Summary: Primary objective: This is a descriptive study and the primary objective is to determine the incidence of injection site and systemic adverse events after Triaxis administration as a 5th dose of tetanus, diphtheria and acellular pertussis vaccine in 4-6 year old children